Gelişmiş Arama

Basit öğe kaydını göster

Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals

dc.contributor.authorGüzel, Eda Çelik
dc.contributor.authorYıldız, Tülin
dc.contributor.authorBüyükkıyıcı, O.
dc.contributor.authorDombaz, O.E.
dc.date.accessioned2023-04-20T08:05:56Z
dc.date.available2023-04-20T08:05:56Z
dc.date.issued2022
dc.identifier.issn0030-9982
dc.identifier.urihttps://doi.org/10.47391/JPMA.4844
dc.identifier.urihttps://hdl.handle.net/20.500.11776/11121
dc.description.abstractObjective: To assess adverse effects post-vaccination in healthcare professionals in the first vaccinated group against coronavirus disease-2019. Method: The prospective study was conducted at the vaccination unit of a university hospital in Tekirdag, Turkey, from January to February 2021, and comprised healthcare professionals who came for receiving the second dose of the coronavirus disease-2019 inactivated severe acute respiratory syndrome coronavirus 2 vaccine 28 days after the first dose. Data was analysed using SPSS 18. Results: Of the 1088 subjects, 714(65.6%) were female with mean age 29.85±9.2 years and 374(34.4%) were male with mean age 29.57±9.85 years. Overall, local pain in the vaccinated area 495(45.5%), fatigue 266(24.4%), headache 261(23.9%) and muscle pain 197(18.1%) were very common adverse effects. Conclusion: Inactivated severe acute respiratory syndrome coronavirus 2 vaccine was found to be safe. © 2022 Pakistan Medical Association. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherPakistan Medical Associationen_US
dc.identifier.doi10.47391/JPMA.4844
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCoronaVacen_US
dc.subjectHealthcare professionalsen_US
dc.subjectPost-vaccination adverse effectsen_US
dc.subjectcoronavacen_US
dc.subjectadulten_US
dc.subjectadverse drug reactionen_US
dc.subjectageusiaen_US
dc.subjectanosmiaen_US
dc.subjectarthralgiaen_US
dc.subjectArticleen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectcoughingen_US
dc.subjectdescriptive researchen_US
dc.subjectdiarrheaen_US
dc.subjectdrug safetyen_US
dc.subjectepiphoraen_US
dc.subjectfatigueen_US
dc.subjectfemaleen_US
dc.subjectfeveren_US
dc.subjectheadacheen_US
dc.subjecthealth care personnelen_US
dc.subjecthumanen_US
dc.subjectinjection site painen_US
dc.subjectloss of appetiteen_US
dc.subjectlymphadenopathyen_US
dc.subjectmaleen_US
dc.subjectmyalgiaen_US
dc.subjectnausea and vomitingen_US
dc.subjectnose obstructionen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectprospective studyen_US
dc.subjectrashen_US
dc.subjectrhinorrheaen_US
dc.subjectSevere acute respiratory syndrome coronavirus 2en_US
dc.subjectskin rednessen_US
dc.subjectskin tinglingen_US
dc.subjectsore throaten_US
dc.subjectswellingen_US
dc.subjectTurkey (republic)en_US
dc.subjectvaccinationen_US
dc.titleSafety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionalsen_US
dc.typearticleen_US
dc.relation.ispartofJournal of the Pakistan Medical Associationen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Aile Hekimliği Ana Bilim Dalıen_US
dc.identifier.volume72en_US
dc.identifier.issue9en_US
dc.identifier.startpage1792en_US
dc.identifier.endpage1796en_US
dc.institutionauthorGüzel, Eda Çelik
dc.institutionauthorBüyükkıyıcı, O
dc.institutionauthorDombaz, O.E.
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid42661653300
dc.authorscopusid55979875100
dc.authorscopusid57907596700
dc.authorscopusid57907393700
dc.identifier.scopus2-s2.0-85138810624en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster